Natural Course of Frailty Components in People Who Develop Frailty Syndrome: Evidence From Two Cohort Studies.


Journal

The journals of gerontology. Series A, Biological sciences and medical sciences
ISSN: 1758-535X
Titre abrégé: J Gerontol A Biol Sci Med Sci
Pays: United States
ID NLM: 9502837

Informations de publication

Date de publication:
23 04 2019
Historique:
received: 05 07 2017
pubmed: 8 8 2018
medline: 27 2 2020
entrez: 8 8 2018
Statut: ppublish

Résumé

Frailty is an important geriatric syndrome, but little is known about its development in the years preceding onset of the syndrome. The aim of this study was to examine the progression of frailty and compare the trajectories of each frailty component prior to frailty onset. Repeat data were from two cohort studies: the Longitudinal Aging Study Amsterdam (n = 1440) with a 15-year follow-up and the InCHIANTI Study (n = 998) with a 9-year follow-up. Participants were classified as frail if they had >3 frailty components (exhaustion, slowness, physical inactivity, weakness, and weight loss). Transitions between frailty components were examined with multistate modeling. Trajectories of frailty components were compared among persons who subsequently developed frailty to matched nonfrail persons by using mixed effects models. The probabilities were 0.43, 0.40, and 0.36 for transitioning from 0 to 1 frailty component, from 1 component to 2 components, and from 2 components to 3-5 components (the frail state). The transition probability from frail to death was 0.13. Exhaustion separated frail and nonfrail groups already 9 years prior to onset of frailty (pooled risk ratio [RR] = 1.53, 95% confidence interval [CI] 1.04-2.24). Slowness (RR = 1.94, 95% CI 1.44-2.61), low activity (RR = 1.59, 95% CI 1.19-2.13), and weakness (RR = 1.39, 95% CI 1.10-1.76) separated frail and nonfrail groups 6 years prior to onset of frailty. The fifth frailty component, weight loss, separated frail and nonfrail groups only at the onset of frailty (RR = 3.36, 95% CI 2.76-4.08). Evidence from two cohort studies suggests that feelings of exhaustion tend to emerge early and weight loss near the onset of frailty syndrome.

Sections du résumé

BACKGROUND
Frailty is an important geriatric syndrome, but little is known about its development in the years preceding onset of the syndrome. The aim of this study was to examine the progression of frailty and compare the trajectories of each frailty component prior to frailty onset.
METHODS
Repeat data were from two cohort studies: the Longitudinal Aging Study Amsterdam (n = 1440) with a 15-year follow-up and the InCHIANTI Study (n = 998) with a 9-year follow-up. Participants were classified as frail if they had >3 frailty components (exhaustion, slowness, physical inactivity, weakness, and weight loss). Transitions between frailty components were examined with multistate modeling. Trajectories of frailty components were compared among persons who subsequently developed frailty to matched nonfrail persons by using mixed effects models.
RESULTS
The probabilities were 0.43, 0.40, and 0.36 for transitioning from 0 to 1 frailty component, from 1 component to 2 components, and from 2 components to 3-5 components (the frail state). The transition probability from frail to death was 0.13. Exhaustion separated frail and nonfrail groups already 9 years prior to onset of frailty (pooled risk ratio [RR] = 1.53, 95% confidence interval [CI] 1.04-2.24). Slowness (RR = 1.94, 95% CI 1.44-2.61), low activity (RR = 1.59, 95% CI 1.19-2.13), and weakness (RR = 1.39, 95% CI 1.10-1.76) separated frail and nonfrail groups 6 years prior to onset of frailty. The fifth frailty component, weight loss, separated frail and nonfrail groups only at the onset of frailty (RR = 3.36, 95% CI 2.76-4.08).
CONCLUSIONS
Evidence from two cohort studies suggests that feelings of exhaustion tend to emerge early and weight loss near the onset of frailty syndrome.

Identifiants

pubmed: 30084927
pii: 5063275
doi: 10.1093/gerona/gly132
pmc: PMC6477647
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

667-674

Subventions

Organisme : Medical Research Council
ID : K013351
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K013351/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R024227/1
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : N01AG50002
Pays : United States

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Lancet. 2013 Mar 2;381(9868):752-62
pubmed: 23395245
Aging Clin Exp Res. 2010 Apr;22(2):100-15
pubmed: 20440097
J Am Geriatr Soc. 2008 Oct;56(10):1910-4
pubmed: 18811604
Arch Intern Med. 2008 Feb 25;168(4):382-9
pubmed: 18299493
J Am Geriatr Soc. 2000 Dec;48(12):1618-25
pubmed: 11129752
J Am Geriatr Soc. 2017 Jan;65(1):179-184
pubmed: 27861714
J Gerontol A Biol Sci Med Sci. 2010 Aug;65(8):887-95
pubmed: 20418349
J Gerontol A Biol Sci Med Sci. 2009 Jan;64(1):76-82
pubmed: 19176328
J Am Geriatr Soc. 2005 Jun;53(6):1069-70
pubmed: 15935037
J Am Geriatr Soc. 2010 Apr;58(4):681-7
pubmed: 20345864
Curr Opin Clin Nutr Metab Care. 2017 Jan;20(1):54-60
pubmed: 27749690
J Am Geriatr Soc. 2011 Mar;59(3):524-9
pubmed: 21391943
J Am Med Dir Assoc. 2014 Apr;15(4):281-6
pubmed: 24534517
Eur J Intern Med. 2016 Jun;31:3-10
pubmed: 27039014
Eur J Epidemiol. 2016 Sep;31(9):927-45
pubmed: 27544533
J Gerontol A Biol Sci Med Sci. 2004 Mar;59(3):255-63
pubmed: 15031310
Maturitas. 2013 Jan;74(1):54-60
pubmed: 23107816
J Gerontol A Biol Sci Med Sci. 2008 Dec;63(12):1389-92
pubmed: 19126853
Int J Epidemiol. 2011 Aug;40(4):868-76
pubmed: 21216744
J Am Med Dir Assoc. 2013 Jun;14(6):392-7
pubmed: 23764209
J Gerontol A Biol Sci Med Sci. 2006 Mar;61(3):262-6
pubmed: 16567375
J Am Geriatr Soc. 2009 Mar;57(3):492-8
pubmed: 19245414
J Am Med Dir Assoc. 2016 Mar 1;17(3):188-92
pubmed: 26805753
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
Am J Epidemiol. 2011 Oct 15;174(8):984-92
pubmed: 21841157
J Am Geriatr Soc. 2010 May;58(5):967-75
pubmed: 20722821
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
Arch Intern Med. 2006 Feb 27;166(4):418-23
pubmed: 16505261
J Gerontol A Biol Sci Med Sci. 2008 Sep;63(9):984-90
pubmed: 18840805

Auteurs

Sari Stenholm (S)

Department of Public Health, University of Turku and Turku University Hospital, Finland.

Luigi Ferrucci (L)

Intramural Research Program, National Institute on Aging, Baltimore, Maryland.

Jussi Vahtera (J)

Department of Public Health, University of Turku and Turku University Hospital, Finland.

Emiel O Hoogendijk (EO)

Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, The Netherlands.

Martijn Huisman (M)

Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, The Netherlands.
Department of Sociology, VU University, Amsterdam, The Netherlands.

Jaana Pentti (J)

Department of Public Health, University of Turku and Turku University Hospital, Finland.
Clinicum, Faculty of Medicine, University of Helsinki, Finland.

Joni V Lindbohm (JV)

Clinicum, Faculty of Medicine, University of Helsinki, Finland.

Stefania Bandinelli (S)

Geriatric Unit, Azienda Sanitaria di Firenze, Florence, Italy.

Jack M Guralnik (JM)

Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore.

Mika Kivimäki (M)

Clinicum, Faculty of Medicine, University of Helsinki, Finland.
Department of Epidemiology and Public Health, University College London Medical School, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH